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ransport and sorting of lipids must occur with speciﬁc
mechanisms because the membranes of intracellular
organelles differ in lipid composition even though
most lipid biosynthesis begins in the ER. In yeast, ceramide
is synthesized in the ER and transferred to the Golgi apparatus
where inositolphosphorylceramide (IPC) is formed. These
two facts imply that ceramide can be transported to the
Golgi independent of vesicular trafﬁc because IPC synthesis
still continues when vesicular transport is blocked in 
 
sec
 
mutants. Nonvesicular IPC synthesis in intact cells is not
T
 
affected by ATP depletion. Using an in vitro assay that
reconstitutes the nonvesicular pathway for transport of
ceramide, we found that transport is temperature and cyto-
sol dependent but energy independent. Preincubation of
ER and Golgi fractions together at 4
 
 
 
C, where ceramide
transport does not occur, rendered the transport reaction
 
membrane concentration independent, providing biochemical
evidence that ER-Golgi membrane contacts stimulate
ceramide transport. A cytosolic protease-sensitive factor is
required after establishment of ER-Golgi contacts.
 
Introduction
 
The membranes of various intracellular compartments of all
eukaryotic cells have distinct lipid compositions (van Meer,
1998; Schneiter et al., 1999). The molecular mechanisms
that establish and maintain these different lipid compositions
are largely unresolved. These processes must be highly regu-
lated to ensure correct membrane assembly for normal cellular
function (Futerman et al., 1998). Lipid localization can be
achieved by the dynamic interplay between local synthesis,
modification, transport, and sorting of various lipids. The
first step in the biosynthesis of most membrane lipids occurs
in the ER, and then lipids travel to their final destination.
This movement must occur selectively by specific mecha-
nisms for each lipid (McIntyre and Sleight, 1994; Trotter
and Voelker, 1994; Liscum and Munn, 1999; van Meer and
Holthuis, 2000; Voelker, 2000). It is assumed that transport
of lipids between intracellular compartments occurs via either
vesicular or nonvesicular transport or both. Nonvesicular
transport could occur by transport of lipid monomers
through the cytosol or by transfer of lipids at regions of close
apposition between membranes. Although several lipid
transfer proteins and mutants defective in lipid transport
have been identified and isolated (Nishijima et al., 1997;
Emoto et al., 1999; Liscum and Munn, 1999; Raggers et al.,
2000), the precise roles of proteins in net transport and sort-
ing of lipids remain unclear.
In mammalian cells, ceramide is formed by decarboxyla-
tion and condensation of L-serine with palmitoyl-CoA, fol-
lowed by reduction of 3-ketodihydrosphingosine to generate
dihydrosphingosine (DHS),* 
 
N
 
-acylation of DHS with a
fatty acid, and finally desaturation of dihydroceramide
(DHS-Cer) (Merrill and Jones, 1990). The biosynthesis of
ceramide seems to occur at the cytosolic surface of the ER in
mammalian cells (Mandon et al., 1992; Hirschberg et al.,
1993), although the ceramide synthase has not been iden-
tified. Ceramide, a common precursor for all complex
sphingolipids, is then transported to the Golgi apparatus
for conversion to both sphingomyelin and glucosylcer-
amide by yet-unknown mechanisms (van Meer and Hol-
thuis, 2000). Recently, it has been shown by in vivo analy-
sis of a mutant resistant to lysenin, an SM-directed
cytolysin, that the transport of ceramide to the sites of
sphingomyelin and glucosylceramide synthesis occurs via a
mechanism that differs from the ER-to-Golgi vesicular
transport of glycoproteins (Fukasawa et al., 1999).
In yeast cells, the steps in ceramide biosynthesis are similar
to those in mammalian cells except that DHS-Cer is hydrox-
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ylated by Sur2p to give phytoceramide (Haak et al., 1997;
Grilley et al., 1998), but the exact localization and topology
of the reactions of ceramide biosynthesis have not been stud-
ied. In contrast to the situation in mammalian cells, it was
assumed that ceramide is converted to inositolphosphoryl-
ceramide
 
 
 
(IPC), one of three major classes of yeast sphin-
golipids, by addition of inositolphosphate from phospha-
tidylinositol (PI) in the ER. Subsequently, IPC was thought
to be delivered to the Golgi apparatus where IPC is mannosy-
lated to form mannosyl-IPC followed by mannosyl-diinosi-
tolphosphorylceramide (Dickson and Lester, 1999; Schneiter,
1999). This idea was based on the fact that IPC synthesis
continued at nonpermissive temperature in 
 
sec
 
 mutants that
block ER-to-Golgi vesicular transport of proteins (Puoti et
al., 1991). Recently, Aur1p, a protein required for IPC syn-
thesis, has been localized to the Golgi apparatus (Levine et al.,
2000), implying that ceramide is delivered to the Golgi appa-
ratus. This suggests that a nonvesicular transport mechanism
exists for ceramide transport to the Golgi apparatus.
In vitro systems that reproduce transport events occurring
in intact cells are powerful tools to understand molecular
mechanisms (Wuestehube and Schekman, 1992; Moreau et
al., 1993; Barlowe et al., 1994; Funakoshi et al., 2000).
Therefore, we have developed a cell-free system with isolated
donor and acceptor membranes that allows us to study the
mechanisms of ceramide transport and ceramide synthesis.
Here, we show that ceramide is transported from the ER to
the Golgi apparatus via two distinct pathways, one vesicle
dependent and the other vesicle and ATP independent. We
provide biochemical evidence that ER-Golgi membrane
contacts play an important role in nonvesicular ceramide
transport. A cytosolic factor is required for transport after
formation of ER-Golgi contacts.
 
Results
 
ER to Golgi 
 
sec
 
 mutants do not completely block 
sphingolipid synthesis
 
In yeast, IPC, the simplest sphingolipid, is made by transfer-
ring inositolphosphate from PI onto ceramide by Aur1p, a
Golgi enzyme (Dickson and Lester, 1999; Schneiter, 1999;
Levine et al., 2000). Previous studies showed that IPC can
be synthesized from radiolabeled DHS or myo-inositol, even
when ER-to-Golgi vesicular transport is blocked in tempera-
ture-sensitive secretion mutants (
 
sec12
 
, -
 
16
 
, -
 
17
 
, -
 
18
 
, and
-
 
23
 
) at restrictive temperature (Puoti et al., 1991; Reggiori
and Conzelmann, 1998). To rule out the possibility that the
lack of complete inhibition was due to newly synthesized
IPC synthase remaining blocked in the ER, the experiment
was repeated in the presence of the protein synthesis inhibi-
tor cycloheximide (Chx). Wild-type or 
 
sec18
 
 mutant cells
were grown at 24
 
 
 
C and then metabolically labeled with
[
 
3
 
H]DHS for 2 h at 24 or 37
 
 
 
C after preincubations with
Chx (Fig. 1 A). Lipids were extracted and deacylated by mild
alkaline hydrolysis to identify radiolabeled lipids and sepa-
rated by TLC. Phosphatidylethanolamine, phosphatidylcho-
line (PC), and PI were completely sensitive to mild alkaline
hydrolysis, whereas sphingolipids were resistant. [
 
3
 
H]myo-
inositol–radiolabeled lipid mixtures and [
 
3
 
H]DHS-1-phos-
phate (DHS-1-P) prepared in vitro from [
 
3
 
H]DHS with
yeast cytosol, and ATP regenerating system were used as
standards to identify PI, IPC/B, IPC/C, and DHS-1-P. At
37
 
 
 
C, wild-type cells showed a decrease in IPC/C synthesis
compared with 24
 
 
 
C. This decrease is due to the presence of
Chx because no reduction was found in absence of Chx (un-
published data). As expected, 
 
sec18
 
 made only 30–45% of
the amount of IPC/C synthesized in the wild-type at 37
 
 
 
C.
This was also seen when the labeling was performed for 30
Figure 1. Incorporation of [
3H]DHS into sphingolipids in sec 
mutants. (A) Wild-type (RH448) and sec18 mutant (RH1737) cells 
were preincubated with Chx for 20 min at 24 C, then incubated for 
20 min at 24 or 37 C, and labeled with [
3H]DHS for 2 h at the same 
temperature. The labeled lipids were subjected ( ) or not ( ) to mild 
alkaline hydrolysis with NaOH and applied to TLC plates using 
solvent I. DHS, phosphatidylethanolamine, PHS, PC, PI, the different 
hydroxylation forms of IPC (Fig. 2 A, IPC-A, -B, and -C), and DHS-1-P 
are marked. (B) Wild-type and sec mutants (RH1737, RH1592, 
RH1491, and RH1436) were preincubated with Chx for 20 min at 
24 C, then incubated for 20 min at 37 C, and labeled with [
3H]DHS 
for 30 min at 37 C. The labeled lipids treated with NaOH were 
applied to TLC plates as above. Incorporation of radioactivity into 
IPC/C was quantified, and the relative amount of IPC synthesis was 
determined as the percentage of the amount in wild-type cells. 
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min, although the reduction in IPC/C synthesis was in-
creased slightly (Fig. 1 B). Similar results can be observed in
other mutants such as 
 
sec17
 
, 
 
sec12
 
, and 
 
sec23
 
, although the
amount of remaining transport varies. The results with the
 
sec12
 
 and 
 
sec23
 
 mutants, which are more specific for ER to
Golgi transport than 
 
sec18
 
, suggest that 
 
 
 
40–50% of ER to
Golgi ceramide transport is nonvesicular under our condi-
tions. Our results confirm previous studies reporting that
IPC/C can be synthesized independently from ER-to-Golgi
vesicular transport and show the importance of the nonve-
sicular pathway.
 
Ceramide and IPC synthesis in vitro
 
Our goal is to study the mechanisms underlying transport of
newly synthesized ceramide to its site of conversion to IPC.
Because an in vitro system using isolated organelles would be
a powerful tool, we first examined the synthesis of IPC by
microsomal membranes from [
 
3
 
H]DHS. When microsomal
membranes were incubated at 24
 
 
 
C with cytosol, ATP-
regenerating system, GDP-mannose, coenzyme A, and lipo-
somes containing hexacosanoic acid (C26) and PI, two sub-
classes of IPC (IPC/B and IPC/C), were synthesized. The
IPC/B and IPC/C comigrated with [
 
3
 
H]myo-inositol–
labeled standards were base resistant, PI-PLC sensitive (Fig.
2 A), and their synthesis was blocked by aureobasidin A
(AbA), an inhibitor of IPC synthesis (Fig. 3 A) (Zhong et
al., 1999).
The identity of ceramide was established by its chemical
characteristics and by using specific inhibitors of ceramide
synthesis. Base-resistant IPCs and presumed ceramides syn-
thesized in vitro were purified from TLC plate by scraping
followed by PI-PLC and/or HCl treatments (Fig. 2, B–D).
The presumed ceramides (Fig. 2 B, lane 5) comigrated with
ceramides derived from base-resistant IPCs treated with PI-
PLC (Fig. 2 B, lane 2) and yielded the sphingoid bases DHS
and PHS and an unidentified lipid X on strong HCl hydrol-
ysis (Fig. 2 B, lanes 3, 4, 7, and 8) in solvent system I. When
solvent system III was used, two different ceramides could
be resolved from PI-PLC–treated IPCs (Fig. 2 C, lane 2).
From the presumed ceramide fractions, we observed one ex-
tra lipid Z, which migrates further than the two ceramides
and was hydrolyzed by HCl (Fig. 2 C, lanes 5 and 6). We
have not further investigated the identity of this lipid. Two
ceramides, *I and *II (Fig. 2 C, lane 6) were purified and hy-
drolyzed individually with HCl. This treatment produced
DHS from ceramide *I. PHS and X were produced from
ceramide *II (Fig. 2 D). These results show that ceramide-1
(*I) is DHS-Cer and ceramide-2 (*II) is a complex of phyto-
ceramide and a ceramide having X. Ceramide-1 and -2 for-
mation was blocked by specific inhibitors of ceramide syn-
thesis, fumonisin B1
 
 
 
(FuB) (Fig. 3 B) (Merrill et al., 1993)
and australifungin (unpublished data) (Mandala et al.,
1995). The inhibition by FuB reveals that ceramide synthe-
sis is based on the fatty acyl-CoA–dependent reaction, not
on the reversal of ceramidases (Mao et al., 2000a,b).
This in vitro system using microsomal membranes
showed that ceramide synthesis is temperature dependent
and requires ATP, cytosol, and a membrane fraction (Fig. 3
B). When the liposomes containing hexacosanoic acid (C26)
and PI were omitted from the reaction mixture, a small re-
duction (18%) in the synthesis of IPCs was found. We also
found that 
 
N
 
-ethylmaleimide (NEM) completely inhibited
ceramide synthesis, suggesting the requirement of an NEM-
sensitive protein or compound (unpublished data).
 
Ceramide and IPC synthase activities are localized in 
the ER and Golgi apparatus, respectively
 
In yeast, no evidence concerning the site of ceramide synthe-
sis has been published. However, IPC synthase activity and
Aur1p have been localized to the Golgi apparatus (Levine et
al., 2000). Therefore, to investigate the transport of cer-
amide it was important to define where ceramide synthesis
activity is located. Subcellular fractionation by sucrose den-
sity gradient of [
 
3
 
H]DHS-labeled membranes expressing
Aur1p-hemagglutinin (HA) showed that the majority of
synthesized ceramides and DHS and DHS-1-P behaved as
Figure 2. Analysis of lipids labeled 
with [
3H]DHS in vitro. (A) In vitro 
[
3H]DHS labeling with microsomal 
membranes and cytosol from RH981 
was performed at 10 C for 15 min and 
then at 4 or 24 C for 2 h as described in 
Materials and methods. Aliquots of the 
labeled lipids were treated or not with 
NaOH or PI-PLC. TLC was performed 
using solvent I. (B and C) In vitro 
[
3H]DHS labeling and NaOH treatment 
of the labeled lipids were performed as 
above. IPCs (lanes 1–4) and presumed 
ceramides (lanes 5–8) were purified 
from the lipids treated with NaOH. 
Aliquots of the purified lipids were 
treated or not with PI-PLC or HCl. TLC 
was performed using solvent I (B) or III 
(C). (D) Lipids *I and *II visible in C, lane 
6, were purified and treated or not with 
HCl. TLC was performed using solvent I. 
X, Y, and Z are unidentified lipids. 
952 The Journal of Cell Biology 
 
|
 
 
 
Volume 155, Number 6, 2001
 
the ER marker Wbp1p, whereas IPCs cosedimented with
Aur1p-HA and Sed5, a marker for Golgi membranes (un-
published data; Banfield et al., 1994; Schröder et al., 1995;
Levine et al., 2000). This result suggests the ER and Golgi
localizations of ceramide and IPC synthesis, respectively.
Next, we investigated whether ceramide and IPC synthesis
could be reconstituted using purified ER- and Golgi-
enriched membranes. ER-enriched membranes were prepared
as described previously (Wuestehube and Schekman, 1992),
and Golgi-enriched membranes were isolated by differential
centrifugation (see Materials and methods). Western blot-
ting analysis showed that Wbp1p was found exclusively in
P27 fraction and P45 fraction, resulting from further frac-
tionation of S27, whereas Emp47p, a Golgi marker
(Schröder et al., 1995) and Aur1p-HA were found mainly in
the final supernatant (S45) (Fig. 4 A). Therefore, we used
the S45 fraction as source of Golgi-enriched membranes
even though a small amount of ER membranes remained in
this fraction. Fractionation of the P27 fraction on a sucrose
gradient resulted in further purification of ER membranes
(at the 40/50% sucrose interface) as shown in Fig. 4 B. Fig.
4 C shows an experiment in which ceramide and IPC syn-
thase activities were examined with the purified ER- and
Golgi-enriched membranes. As expected, efficient synthesis
and subsequent conversion of ceramide to IPC required the
addition of both ER- and Golgi-enriched membranes.
When only ER membranes were incubated, the amount of
ceramide synthesized remained high (87% of complete incu-
bation), but the level of IPC synthesis was low. This con-
firms that IPC synthase activity is localized in Golgi mem-
branes. In contrast, addition of only Golgi membranes
resulted in significant reductions of ceramide and IPC syn-
thesis by 41 and 27%, respectively. Since a detectable
amount of Wbp1p was found in the Golgi membrane frac-
tion, the lack of complete loss of ceramide synthase activity
is most likely due to ER contamination in the Golgi frac-
tion. The above results are consistent with the localization of
ceramide synthesis to the ER. Ceramide would then be
transported to the Golgi apparatus for conversion to IPC.
 
Properties of ceramide transport in vitro
 
To study the transport of ceramide from ER to the Golgi
compartment, we next developed a two stage in vitro assay
that is based on the conversion of ceramide to IPC. In the
first stage, radiolabeled ceramides are synthesized by incu-
bating ER-enriched membranes in the presence of cytosol,
ATP-regenerating system, substrates, and AbA for 2 h at
24
 
 
 
C. Ceramide synthesis from [
 
3
 
H]DHS with the ER-
enriched membranes also requires ATP and cytosol and is
temperature and time dependent (unpublished data). AbA
was used to block any IPC synthase activity coming from
contamination of Golgi membranes in the ER fraction. Af-
ter ceramide synthesis, the ER membranes were washed by
centrifugation (27,000 
 
g
 
, 10 min, 4
 
 
 
C). The recovery of ra-
diolabeled ceramides was 
 
 
 
85%. In the second stage, an ac-
ceptor membrane and cytosol, ATP-regenerating system,
substrates, AbA, and FuB (to block further ceramide synthe-
sis) were added to the ER membrane fraction containing
[
 
3
 
H]ceramide. Microsomal membranes prepared from an
AbA-resistant strain were used as acceptor membranes be-
cause the AbA-resistant but not wild-type cells can make
IPCs in the presence of AbA in vivo (Fig. 5 A). Microsomal
membranes prepared from the AbA-resistant cells are resis-
tant to AbA but are sensitive to FuB (unpublished data). Fig.
5 B shows the basic features of the in vitro ceramide trans-
port assay. When acceptor membranes from the AbA-resis-
tant strain were used in a complete reaction mixture, cer-
amides were converted to IPC, indirectly assaying transport of
ceramide from ER to the Golgi membranes. The amount of
ceramide remaining in the reaction mixture was reduced af-
ter incubation at 24
 
 
 
C compared with at 4
 
 
 
C (unpublished
data). As a negative control, no conversion was detected
with acceptor membranes from a wild-type strain. The con-
version of ceramide to IPC had a strong requirement for cy-
tosol. The reaction continued for 120 min with a lag of 15
min (Fig. 5 C), which varied depending upon the experi-
ment and preparations (see Fig. 7, A–C). The reaction was
temperature dependent because no conversion of ceramide
to IPC occurs at 4
 
 
 
C (unpublished data). Depletion of ATP
did not affect the conversion of ceramide to IPC, suggesting
that ceramide transport occurs in our system in an ATP-
Figure 3. Requirements for ceramide and IPC synthesis in vitro. 
(A and B) In vitro [
3H]DHS labeling under different conditions as 
indicated and NaOH treatment of the labeled lipids were performed 
as described in the legend to Fig. 2 A. To the samples containing no 
ATP-regenerating system, apyrase (0.5 U, 10 U/ml) was added. FuB 
and AbA were used at 100  M and 50 nM, respectively. TLC was 
performed using solvent I (A) or III (B). 
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independent manner. The reaction was dependent on the
amount of acceptor membranes, being linear up to 
 
 
 
50 
 
 
 
g
(protein concentration) of acceptor membranes. (Fig. 5 D).
To test for specificity of transfer of ceramide from ER to
Golgi, we took 25 
 
 
 
g of acceptor membranes and added in-
creasing concentrations of competitor membranes. If trans-
fer is specific, then microsomal membranes from wild-type
cells (AbA sensitive) should inhibit IPC synthesis. This was
the case (Fig. 5 E). If the transfer of ceramide occurs to any
membrane, then mitochondria should also be able to com-
pete, which they did not (Fig. 5 E).
Since cytosol was required for conversion of ceramide to
IPC, we next tested whether the cytosolic component was
specific and proteinaceous (Table I). The cytosol require-
ment was specific because BSA could not substitute for cyto-
sol. Furthermore, addition of Triton X-100 resulted in an al-
most complete loss of the cytosol requirement, suggesting
that cytosol is required for ceramide transport but not IPC
synthase activity. Cytosol treated with trypsin or treated at
95
 
 
 
C for 15 min did not support the efficient conversion to
IPC. These results indicate that a heat-labile and trypsin-
sensitive cytosol protein(s) is required for ceramide trans-
port. In contrast, treatment of donor, acceptor, or both
membranes with trypsin had little inhibitory effect on con-
version of ceramide to IPC, although under the same condi-
tions trypsin treatment resulted in complete removal of the
HA epitope tag from the COOH terminus of Aur1p (un-
published data).
The next set of experiments was performed to determine
whether ceramide transport in our assay requires ER-to-
Golgi vesicular transport. Several studies using in vitro cell-
free assays have shown that NEM and nonhydrolyzable ana-
logs of GTP such as GTP
 
 
 
S inhibit ER-to-Golgi-vesicular
transport (Baker et al., 1990; Barlowe et al., 1994). As seen
in Fig. 6 A, neither GTP
 
 
 
S nor NEM had a strong inhibi-
tory effect on ceramide transport. The nonvesicular nature
of the transport reaction was confirmed by using cytosol and
microsomal membranes from 
 
sec18
 
 mutant cells, which are
defective for delivery of ER-derived vesicles to the Golgi at
restrictive temperature in vitro (Muñiz et al., 2001). Forma-
tion of IPC was monitored by a one step assay at permissive
(24
 
 
 
C) and restrictive (30 and 37
 
 
 
C) temperatures. Al-
though high temperature reduced the extent of IPC synthe-
sis in both wild-type and 
 
sec18
 
 extracts, no specific defect in-
the 
 
sec18
 
 mutant was detected (Fig. 6 B). Therefore, our
results demonstrate that transport of ceramide from ER to
Figure 4. Reconstitution of ceramide and subse-
quent IPC synthesis with ER- and Golgi-enriched 
membranes. (A and B) Purification of ER- and 
Golgi-enriched membranes was performed as 
described in Materials and methods. (A) Microsomal 
membranes from RH5256 were subjected to 
sequential centrifugation to obtain pellet (P27), 
supernatant (S27) fraction, and from the S27 
fraction, pellet (P45), supernatant (S45) fraction. (B) 
The P27 fraction was subjected to sucrose density 
step gradient, and the resulting gradient fractions 
were collected from the top. Equal fractions were 
analyzed for the distribution of Aur1p-HA, 
Emp47p, and Wbp1p by Western blotting. (C) In 
vitro labeling using [
3H]DHS with either ER- 
(40/50%-I fraction, 5–10  g) or Golgi- (S45 
fraction, 25–50  g) enriched membranes or both 
(40/50%-I fraction, 5–10  g and S45 fraction, 
25–50  g), and NaOH treatment of the labeled 
lipids were performed as described in the legend to 
Fig. 2 A. Control experiments were done without 
membranes or with both membranes in the 
presence of AbA (50 nM). The lipids were applied 
to TLC plates using solvent I. Images of portions of 
individual lanes were shown, and the maximal 
signal of [
3H]ceramide in the experiment, which 
was done with both membranes, was set to 100 
as the relative signal. In these diagrams, the total 
amount of incorporation of [
3H]DHS into each 
lipid was expressed as the percentage of that of 
[
3H]DHS with both membranes. 
954 The Journal of Cell Biology 
 
|
 
 
 
Volume 155, Number 6, 2001
 
the Golgi compartment in our assay occurs by nonvesicular
transport.
Two mechanisms for nonvesicular transport between
membranes have been postulated. One is transfer of lipid
through the cytosol and the other is transfer of lipid through
direct membrane contacts (McIntyre and Sleight, 1994;
Trotter and Voelker, 1994). The former should be strongly
dependent on ER and Golgi membrane concentrations
throughout the reaction. However, preliminary experiments
suggested that the reaction was dilution independent at sev-
eral time points of the reaction at 24
 
 
 
C. Therefore, we ex-
amined the effect of dilution on ceramide transport after a
preincubation of donor and acceptor membranes together at
4
 
 
 
C where transport does not occur. Fig. 7 A shows the ki-
netics of ceramide transport with different preincubation
conditions. IPC synthesis was not affected by dilution after
premixing of membranes at 4
 
 
 
C for 5 min. Control experi-
ments showed that when membranes were diluted indepen-
dently before the mixing (0 min preincubation), no time-
dependent conversion of ceramide to IPC was observed (Fig.
7 B). Therefore, once the two membranes have been prein-
cubated at 4
 
 
 
C, synthesis of IPC is a zero order reaction with
respect to membranes. This strongly suggests that ceramide
transport occurs through ER-Golgi membrane contacts. In
addition, we found that when donor and acceptor mem-
branes were preincubated at 4
 
 
 
C with cytosol and then di-
luted without cytosol, no efficient conversion of ceramide to
IPC was observed (Fig. 7 C), demonstrating that cytosol is
required after ER-Golgi membrane contacts. In contrast,
preincubation at 4
 
 
 
C without cytosol and subsequent dilu-
tion with cytosol did not affect the conversion of ceramide
to IPC. Therefore, cytosol is not required under our condi-
tions to establish ER-Golgi membrane contacts.
 
Depletion of ATP does not affect 
 
SEC18
 
-independent 
ceramide transport in vivo
 
IPC synthesis still continues even though inhibited when
ER-to-Golgi vesicular transport is blocked in 
 
sec
 
 mutant cells
(Fig. 1, A and B). Our in vitro results suggest that 
 
SEC
 
-inde-
pendent IPC synthesis is mediated by ATP-independent
transport of ceramide (Fig. 5, B and C, and Fig. 6 A). Since
incorporation of [
 
3
 
H]myo-inositol into PI occurs at a lower
temperature than the incorporation into IPC (Puoti et al.,
1991), this difference allowed us to examine the effect of
ATP depletion on 
 
SEC18
 
-independent IPC synthesis in in-
tact cells in an experiment that measures the synthesis of
Figure 5. Cytosol- but not ATP-dependent 
transport of ceramide in vitro. (A) Wild-type 
(WT, RH5247) and AbA-resistant (RH5255) cells 
were preincubated with ethanol or AbA (20  g/ml) 
for 20 min at 24 C and then labeled with [
3H]DHS 
for 30 min at the same temperature. Lipid analysis 
was performed as described in the legend to Fig. 1 
A. (B) In vitro ceramide transport assay was 
performed in the presence ( ) or absence ( ) of 
cytosol or ATP as described in Materials and 
methods. To the samples containing no ATP, 
apyrase was added, and lipid analysis was 
performed as described in the legend to Fig. 3 A. 
Control experiments were done without or with 
acceptor membranes from wild-type (RH5247). 
(C and D) In vitro ceramide transport assay was 
performed in the presence or absence of cytosol 
for indicated times (C) and in the presence of 
cytosol for 60 min with indicated amounts of the 
acceptor membranes (D) under ATP-depletion 
conditions as described above. (E) In vitro 
ceramide transport assay was performed with 25 
 g of acceptor membranes as described in D. The 
indicated amounts of microsomal membranes 
(RH5247) or purified mitochondria (D273-10B) 
from wild-type strains were added as competitors 
before the second stage reaction. Ceramide trans-
port (%) was determined by quantification of the 
total amount of the incorporation of [
3H]ceramide 
into IPC and was expressed as the percentage of 
values of the experiment without competitor 
membranes.Ceramide transport from ER to Golgi apparatus | Funato and Riezman 955
sphingolipids from endogenously synthesized ceramides.
Mutant sec18 cells were labeled with [
3H]myo-inositol at
1–3 C for 45 min and further incubated with NaF and
NaN3 at 1–3 C for 10 min to allow depletion of ATP. Sub-
sequently, the cells were chased at 37 C for 30 min. During
the pulse at 1–3 C, very little IPC/C was synthesized. When
sec18 mutant cells were chased at 37 C, approximately three
times more IPC/C was produced. This increase in IPC/C
synthesis was not affected by depletion of ATP (Fig. 8). We
conclude that transport of ceramide from the ER to the
Golgi apparatus by the nonvesicular (SEC18-independent)
pathway in intact cells does not require ATP, and therefore
this process reflects the ceramide transport we reconstituted
in vitro.
Discussion
Transport of lipids between subcellular compartments must
be achieved by one or more of the following possible mecha-
nisms: vesicular transport with budding of vesicles from do-
nor membranes and targeting/fusion with the acceptor
membranes, transfer of lipid monomers through the cytosol,
or transfer of lipid through membrane contacts (McIntyre
and Sleight, 1994; Trotter and Voelker, 1994; Liscum and
Munn, 1999; van Meer and Holthuis, 2000; Voelker,
2000).
Our study provides evidence that ceramide is transported
from the ER to the Golgi apparatus by both vesicular and
nonvesicular means in yeast. From in vivo experiments, IPC
synthesis from radiolabeled DHS was reduced but still ob-
served when ER-to-Golgi vesicular transport was blocked in
temperature-sensitive secretion mutants even under the con-
ditions where protein synthesis was also blocked in sec18
mutant cells. This SEC18-independent IPC synthesis was
also not affected by ATP depletion. Consistent with this,
IPC synthesis was inhibited partially by ATP depletion in
wild-type cells (unpublished data). These results suggest that
ceramide is transported from the ER to the Golgi apparatus
via two distinct pathways in intact cells, one vesicle depen-
dent and the other nonvesicular. Analysis using an in vitro
assay demonstrated that transport of ceramide from the ER
to the Golgi compartment was not sensitive to ATP deple-
tion and was SEC18 independent, indicating a nonvesicular
transport mechanism. The correlation between in vivo and
in vitro experiments provides evidence that the in vitro assay
for ceramide transport measures a physiologically relevant
transport process.
Some previous studies have suggested that nonvesicular
transport of ceramide in vitro does not require cytosol
(Moreau et al., 1993; Kok et al., 1998). Recently a cytosolic
protein requirement has been demonstrated using semiintact
cells to measure ceramide transport from the ER to the site
of synthesis of sphingomyelin in the Golgi compartment
(Funakoshi et al., 2000). In vitro analysis with the LY-A
mutant, displaying a specific defect in ER-to-Golgi traffick-
ing of ceramide to the site of sphingomyelin synthesis,
showed that LY-A mutant cells are defective in a cytosolic
protein involved in the ceramide transport. Since ER-to-
Golgi transport of GPI-anchored or transmembrane pro-
teins in LY-A cells appeared to be normal, it was suggested
that ceramide is delivered to the Golgi apparatus by a mech-
anism that differs from ER-to-Golgi vesicular transport of
proteins. Although the delivery of ceramide from the ER to
the Golgi apparatus is mediated by two pathways, ATP-
dependent and ATP-independent (nonvesicular), the defect
Table I. Cytosolic protein is required for ATP-independent 
transport of ceramide
Transport
Addition  ATP  ATP
(%)
Untreated cytosol 100 100
No cytosol (B88) 8 0
No cytosol (B88 containing BSA) 0 0
Treated cytosol
+ Trypsin, 30 min, 4°C, + trypsin inhibitor  9 16
+ Trypsin + trypsin inhibitor, 30 min, 4°C 87 117
15 min, 95°C 0 0
Untreated cytosol + 1% Triton X-100 100 ND
No cytosol (B88) + 1% Triton X-100  99 ND
Cytosolic protein is required for ATP-independent transport of ceramide. In
vitro ceramide transport assay was performed with untreated or treated
cytosol in the presence or absence of ATP as described in the legend to Fig.
5 B. For trypsin treatment, cytosol was treated with trypsin (1.25 mg/ml) for
30 min at 4 C and quenched with soybean trypsin inhibitor (5 mg/ml). In
control treatments, soybean trypsin inhibitor was added before addition of
trypsin. For heat treatment, cytosol was incubated for 15 min at 95 C and
centrifuged for 1 min at 12,000 g, and the resulting supernatant was used
for the assay. If present, Triton X-100 (1%) was added to reaction mixtures
for 20 min at 4 C before the reaction. Lipid analysis was performed and
ceramide transport (%) was determined as described in the legend to Fig. 5
C. ND, not determined.
Figure 6. Ceramide is transported via a nonvesicular pathway. (A) 
In vitro ceramide transport assay were performed in the presence of 
cytosol and ATP as described in the legend to Fig. 5 B. GTP S (0.4 
mM), GTP (0.4 mM), GTP (0.4 mM) plus Sar1p (90  g/ml), or NEM 
(10 mM) was added just before the second stage reaction. (B) In 
vitro [
3H]DHS labeling with cytosol and microsomal membranes 
from wild-type (RH981) or sec18 mutant (RH2043) cells at different 
temperatures and lipid analysis were performed as described in the 
legend to Fig. 2 A.956 The Journal of Cell Biology | Volume 155, Number 6, 2001
in LY-A cells is specific to ATP-dependent trafficking of cer-
amide (Fukasawa et al., 1999). It is not clear whether the
ATP-dependent delivery of ceramide is via one of multiple
vesicular pathways that is specific for ceramide or nonvesicu-
lar pathways. In this respect, evidence for the existence of
two distinct vesicle populations upon budding from the ER
was provided recently (Muñiz et al., 2001).
The dilution independence of ceramide transport after ER
and Golgi membranes have been incubated together at 4 C,
where transport does not occur, strongly suggests that stable
membrane contacts are formed and that these are relevant to
the nonvesicular transport process. The ER-to-Golgi mem-
brane contacts are likely to be saturable and specific for cer-
amide transport, since microsomes from wild-type cells in-
hibited ceramide transport in vitro, whereas addition of
purified mitochondria did not. Our data provide important
biochemical evidence for a role of membrane–membrane
contacts in intracellular lipid transport and provide a system
to begin to characterize this process.
Experimental evidence for an important function of mem-
brane contacts has been found for ER-to-mitochondria traf-
ficking of phosphatidylserine (Voelker, 1993; Achleitner et
al., 1999). In addition, a close apposition of trans-ER with
trans-Golgi cisternae has been reported by a high voltage
electron microscope tomographic study (Ladinsky et al.,
1999). Since the trans-ER lacks buds, it is most likely that
this close apposition is associated with transport of lipids via
nonvesicular rather than with vesicular transport of proteins.
ER-to-Golgi transport of ceramide for glucosylceramide
synthesis was almost independent of ATP and cytosol (Funa-
koshi et al., 2000). In contrast, our experiments have shown
that ATP-independent nonvesicular transport of ceramide re-
Figure 7. Ceramide transport occurs through ER-Golgi membrane 
contacts. In vitro ceramide transport assay was performed under ATP 
depletion conditions as described in the legend to Fig. 5 C. (A) For 
dilution experiments, the reaction mixtures for transport assay 
prepared on ice were preincubated at 4 C for 5 min or at 24 C for 15 
min and then diluted 10-fold with B88 containing cytosol (2 mg/ml), 
GDP-mannose (50  M), liposomes composed of PI (250  M), and 
Apyrase (10 U/ml). (B) The reaction mixtures containing donor and 
acceptor membranes were prediluted independently fivefold with 
dilution buffer before the mixing. (C) The reaction mixtures prepared 
in the presence or absence of cytosol were preincubated at 4 C for 5 
min and then diluted 10-fold with dilution buffer with or without 
cytosol. At the indicated times for 24 C incubation, 50- l aliquots 
from the undiluted or 500- l aliquots from the diluted reaction 
mixtures were withdrawn. Lipid analysis of the mixtures was 
performed, and ceramide transport (transport in undiluted reaction 
set to 100%) was determined as described in the legend to Fig. 5 C.
Figure 8. SEC-independent IPC biosynthesis does not require ATP 
in intact cells. Mutant sec18 (RH1737) cells labeled with [
3H]myo-
inositol were subjected to ATP depletion procedure and then 
chased at restrictive temperature as described in Materials and 
methods. The labeled lipids were applied to TLC plates using sol-
vent II. PI, IPC/C, lysophosphatidylinositol (Lyso-PI), mannosyl-IPC 
(MIPC), mannosyl-diinositolphosphorylceramide (M[IP]2C), and X-I 
(unidentified lipid) are marked.Ceramide transport from ER to Golgi apparatus | Funato and Riezman 957
quires a heat-labile and trypsin-sensitive cytosol protein(s).
To our knowledge, this is the first clear evidence for a cytoso-
lic protein requirement for nonvesicular transport of cer-
amide. What could be the function of this cytosolic factor?
Our dilution experiments have shown that the cytosol re-
quirement is involved in the late step of ceramide transport after
establishment of ER-Golgi membrane contacts. Thus, the cyto-
solic protein(s) seems to be required for transfer of ceramide
from ER to Golgi membranes. It is unlikely that a cytosolic fac-
tor would be required for the transbilayer movement of cer-
amide after it has reached the Golgi compartment. Therefore,
the late cytosolic requirement also makes it unlikely that cer-
amide is transferred from ER to Golgi during our short incuba-
tion at 4 C. The processes of membrane–membrane contact
and transfer could be obligatorily coupled because cytosol could
not efficiently extract ceramide out of the ER without acceptor
membranes (unpublished data).
Analysis using our in vitro transport assay also revealed
that ER-to-Golgi transport of ceramide continues for  60
min with a lag period from 5 to 15 min. The rather long
time requirement could be due to ceramide transport to the
Golgi complex and/or reflect the need to translocate cer-
amide from the cytosolic to the lumenal side of Golgi appa-
ratus. Based on the predicted topology of Aur1p and local-
ization of its putative active site in the lumen of the Golgi
compartment, this translocation step would be required in
our assay (Levine et al., 2000). A lumenal active site is con-
sistent with our findings that trypsin treatment of mem-
branes did not destroy conversion of ceramide to IPC. The
half times for spontaneous translocation of short acyl chain
ceramide (C5-DMB-ceramide) across lipid bilayers has been
reported to be 22 min (Bai and Pagano, 1997), but measure-
ments for natural ceramides are not available. Since short
acyl chain lipids appear to undergo rapid transbilayer move-
ment, on the basis of the correlation between the hydropho-
bicity of acyl chain and the rate of transbilayer movement
(Bai and Pagano, 1997), it would follow that the spontane-
ous translocation of natural ceramide would occur in the or-
der of hours and that specific proteins must be involved in
the movement of ceramide. This translocation should be
ATP independent because nonvesicular transport of cer-
amide does not require ATP. Such specific lipid transloca-
tors or flippases exist in the ER, Golgi apparatus, and plasma
membrane (Raggers et al., 2000). Most of them require
energy (e.g., ATP), but some proteins such as scramblase
are involved in ATP-independent transbilayer lipid move-
ment. In addition, ATP-independent protein-mediated lipid
movement has been postulated in the translocation of gluco-
sylceramide from the cytosolic to the lumenal leaflet of the
Golgi membranes.
Our in vitro transport assay seems to reconstitute only the
nonvesicular ceramide transport pathway. The reasons for
the lack of reconstitution of the vesicular pathway are not
clear, but in yeast the Golgi apparatus is made up of appar-
ently unconnected compartments. Aur1p is located prima-
rily in the medial-Golgi but not cis-Golgi compartments
(Levine et al., 2000). Therefore, it seems plausible that cer-
amide transported to the cis-Golgi compartment via vesicu-
lar mechanism could be not delivered to the IPC synthase
compartment efficiently in our assay because it involves too
many transport steps. This may help explain why GTP plus
Sar1p inhibits ceramide transport in our assay. GTP and
Sar1p stimulate vesicle budding (Barlowe et al., 1994), and
ceramide could be sequestered in these vesicles. In any event,
it seems likely that nonvesicular pathway is used directly to
generate IPC. To show that the direct fusion of ER with
Golgi membranes did not occur under our assay conditions,
we assayed for the acquisition of  -1,6 mannose modifica-
tions onto the ER form of the GPI-anchored protein, Gas1p
(Muñiz et al., 2001). Less than 5% (background) of the
Gas1p received this modification. Therefore, this cannot ac-
count for the  20% transport of ceramide that we see in
our assay (unpublished data).
We postulate that the two different pathways of ceramide
transport may have different functions. Vesicular-dependent
transport would function to establish and maintain the lipid
composition of ER and Golgi membranes during ER to
early Golgi trafficking associated with possible functions of
ceramide in regulation of cellular processes (Futerman et al.,
1998; Hannun and Luberto, 2000) such as protein transport
and signal transduction. For example, the sorting of GPI-
anchored proteins from the ER is regulated by sphingoid
base or ceramide synthesis (Horvath et al., 1994; Sütterlin et
al., 1997). Nonvesicular transport would function to pro-
vide ceramide directly for de novo biosynthesis of sphin-
golipids for their important roles. These hypotheses will be
addressed by further studies of the molecular mechanisms
underlying the nonvesicular transport of ceramide.
Materials and methods
Strains
The secretion mutant strains used in this work were RH1737 (MATa
sec18–20 his4 leu2 ura3 bar1), RH2043 (MATa sec18–20, his4 leu2 ura3
bar1 pep4::URA3), RH1592 (MATa sec17–1 his4 leu2 ura3 lys2 bar1),
RH1491 (MATa sec12–4 his4 leu2 ura3 lys2 bar1), RH1436 (MATa sec23–1
his4 leu2 ura3 bar1), and the corresponding wild-type strains RH448
(MATa his4 leu2 ura3 lys2 bar1) and RH981 (MATa his4 leu2, ura3 lys2
bar1 pep4::URA3). Three copies of the HA epitope were introduced at the
COOH terminus of Aur1p as described previously (Levine et al., 2000) by
transformation of strain RH5247 (MATa his3 leu2 ura3 lys2 barl pep4–3) to
yield RH5256 (MATa aur1::AUR1 3xHA HIS5Sp his3 leu2 ura3 lys2 barl
pep4–3). Epitope tagging was confirmed by Western blotting. An AbA-
resistant strain, RH5255 (MATa aur1::AUR1-C his3 leu2 ura3 lys2 barl
pep4–3), was generated by transformation of RH5247 with the StuI/SmaI
DNA fragment from pAUR101 integrating vector, which has mutant
AUR1-C (Takara Shuzo Co., Ltd.) (Hashida-Okado et al., 1996, 1998) and
isolated on YPD plates containing 2  g/ml of AbA. Strain (D273–10B,
MAT  ATCC25657) was used for isolation and purification of mitochon-
dria as described (Glick and Pon, 1995).
In vivo labeling with [
3H]DHS and [
3H]myo-inositol
Cell cultures and labeling of lipids with [
3H]DHS was performed as de-
scribed previously (Zanolari et al., 2000). If present, Chx (200  g/ml; Fig.
1, A and B) and AbA (20  g/ml; Fig. 5 A) were added, and cells were incu-
bated for 20 min at 24 C before preincubation and at the start of the prein-
cubation, respectively.
For the energy deprivation experiments, sec18 cells were preincubated
for 20 min at 1–3 C and labeled with [
3H]myo-inositol at 1–3 C. After 45
min, myo-inositol (100  g/ml) and NaF/NaN3 (each 10 mM) were added
and incubated for 20 min at 1–3 C. The cells were then chased for 30 min
at 37 C after the addition of 4 vol of SD medium containing myo-inositol.
After the incubations, cells were placed on ice and washed, and cell
pellets were subjected to lipid extraction (Zanolari et al., 2000). If neces-
sary, the extracted lipids were submitted to mild alkaline hydrolysis with
NaOH. After neutralization with acetic acid, the lipids were desalted by
partitioning between N-butanol and water. The pooled organic phases
were dried under nitrogen. The lipids were dissolved in chloroform/metha-
nol/water (CMW; 10/10/3 [vol/vol/vol]) for TLC on Kieselgel 60 plates
(20   20; Merck) and developed in solvent I (chloroform/methanol/4.2 N958 The Journal of Cell Biology | Volume 155, Number 6, 2001
NH4OH, 9/7/2 [vol/vol/vol]) or solvent II (chloroform/methanol/0.25%
KCl, 55/45/10 [vol/vol/vol]). Radiolabeled lipids were visualized and
quantified on a Cyclone Storage Phosphor System using a tritium-sensitive
screen (Packard).
Cytosol and membrane preparations
Cytosols were prepared from RH981 and RH2043 strains as described
(Salama et al., 1993). The preparation of microsomal membranes and ER-
enriched membranes were performed as described (Baker et al., 1990;
Wuestehube and Schekman, 1992) with a few modifications. In brief,
spheroplasts (from 0.5 OD600 U of cells in log phase, total 4   10
10 cells)
were lysed in lysis buffer (0.1 M sorbitol, 20 mM Hepes, pH 7.4, 150 mM
potassium acetate, 2 mM EDTA, 1 mM DTT, 1 mM PMSF, and 1  g/ml pro-
tease inhibitor mixture [pepstatin, leupeptin, antipain]). Unbroken cells
and cell debris were removed by centrifugation (3000 g, 10 min, 4 C), and
the resulting supernatants were centrifuged (100,000 g, 1 h, 4 C) to collect
the microsomal membrane fraction. The pellet was washed twice and re-
suspended in 1 ml (25–50 mg protein) of B88 (20 mM Hepes-KOH, pH 6.8,
150 mM potassium acetate, 5 mM magnesium acetate, 250 mM sorbitol).
Aliquots were frozen in liquid nitrogen and stored at  80 C. For ER- and
Golgi-enriched membranes, supernatants containing microsomal mem-
branes were subjected to two successive centrifugation steps (27,000 g, 10
min, 4 C) giving rise to pellet (P27) and supernatant (S27) fractions, and
S27 was centrifuged (45,000 g, 15 min, 4 C), resulting in P45 and S45. S45
containing Golgi-enriched membranes was spun (100,000 g, 1 h, 4 C),
washed twice, and resuspended in 1 ml (10–20 mg protein) of B88. P27
was resuspended in lysis buffer and loaded onto a 7.5 ml sucrose density
step gradient (2.5 ml each of 40, 50, and 60% sucrose in 10 mM Hepes,
pH 7.4, 1 mM MgCl2). The gradient was centrifuged at 200,000 g for 2 h
and 20 min at 4 C in TST41.14 rotor (Kontron Instruments). The ER-
enriched membrane fraction at the 40/50% sucrose interface was col-
lected, washed twice by centrifugation (27,000 g, 10 min, 4 C), and resus-
pended in 1 ml (2–4 mg protein) of B88. Aliquots of each membrane fraction
were frozen in liquid nitrogen and stored at  80 C. Protein concentrations
were determined using the protein assay kit from Bio-Rad Laboratories.
In vitro labeling with [
3H]DHS
To assay for ceramide and IPC synthase activities, microsomal membranes
(100–200  g) or membrane fractions (ER-enriched membranes, 5–10  g;
Golgi-enriched membranes, 25–50  g), cytosol (100  g), ATP regenerat-
ing system (1 mM ATP, 40 mM phosphocreatine, 0.2 mg/ml creatine phos-
phokinase), GDP-mannose (50  M), and a mix of [
3H]DHS and unlabeled
DHS (10 and 40 pmoles, respectively, 0.5  Ci) were first incubated (15
min, 10 C) for incorporation of DHS into membranes. Coenzyme A (50
 M) and liposomes containing hexacosanoic acid (C26) and PI (50 and 250
 M, respectively) prepared as described (Funato et al., 1992) were added,
and the mixture was incubated (2 h, 24 C) in a final volume of 50  l of
B88. The reaction was stopped by adding 333  l of chloroform/methanol
(CM; 1/1 [vol/vol]). The organic phase was collected after centrifuging at
13,000 g for 5 min, and the pellet was reextracted with 250  l of CMW.
The extracted lipids were submitted to a mild alkaline treatment, N-buta-
nol extraction, and analyzed by TLC with solvent I as described above. Ra-
diolabeled ceramide was analyzed with solvent III (chloroform/acetic acid,
9/1 [vol/vol]) (Morell and Radin, 1970).
In vitro ceramide transport assay
Radiolabeled ceramide was synthesized in vitro from [
3H]DHS using ER-
enriched membranes (10–20  g) as described above except that GDP-
mannose was omitted, AbA (0.2  M) was included in the assay mixture,
and liposomes containing hexacosanoic acid (C26) and PC were used in-
stead of liposomes containing hexacosanoic acid (C26) and PI. The mem-
branes were then recovered by centrifugation at 27,000 g for 10 min at
4 C, washed twice, resuspended in B88, and used as the donor membrane
in the in vitro transport assay. The recovery of radiolabeled lipids was 50–
75% percent of the total. Subsequently, the donor membranes were in-
cubated for 2 h at 24 C in the total reaction mixture (50  l) containing
cytosol (2 mg/ml), ATP regenerating system, GDP-mannose (50  M), lipo-
somes composed of PI (250  M), FuB (200  M), AbA (0.4  M), and
microsomal membranes (50–100  g) prepared from AbA-resistant strain
(RH5255) as the acceptor membrane to allow transport to occur. The reac-
tion was stopped by adding 333  l of CM. The preparation of the lipid ex-
tracts and analysis were done as described above.
Lipid analysis
Radiolabeled lipids were collected from TLC plates by scraping and elut-
ing with CMW. The isolated lipid extract was dried under nitrogen and
partitioned between N-butanol and water. Lipid mixtures (Fig. 2 A) or iso-
lated lipids (Fig. 2, B–D) were subjected to phosphoinositide-specific PLC
digestion as described previously (Hamburger et al., 1995). Strong HCl hy-
drolysis of lipids was performed as described (Puoti et al., 1991). After en-
zymatic and/or chemical treatments, lipids were dried under nitrogen and
partitioned between N-butanol and water. After drying, the lipids were dis-
solved in CMW and analyzed by TLC as described above.
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